Hinge Health (NYSE:HNGE) Now Covered by Truist Financial

Truist Financial assumed coverage on shares of Hinge Health (NYSE:HNGE) in a research report report published on Monday morning, Marketbeat reports. The brokerage issued a buy rating and a $48.00 target price on the stock.

A number of other research firms have also recently commented on HNGE. Morgan Stanley began coverage on Hinge Health in a research report on Monday. They issued an “overweight” rating and a $46.00 price objective for the company. Barclays began coverage on Hinge Health in a research report on Monday. They set an “overweight” rating and a $43.00 price target for the company. Piper Sandler began coverage on Hinge Health in a research note on Monday. They set an “overweight” rating and a $41.00 price objective on the stock. KeyCorp began coverage on Hinge Health in a research note on Monday. They set an “overweight” rating and a $45.00 price objective on the stock. Finally, Canaccord Genuity Group began coverage on Hinge Health in a research note on Monday. They set a “buy” rating and a $52.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $46.00.

Hinge Health Stock Performance

Shares of HNGE stock opened at $36.65 on Monday. Hinge Health has a twelve month low of $33.42 and a twelve month high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.